مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

239
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

146
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

The effect of nanomicelle curcumin, sorafenib, and combination of the two on the cyclin D1 gene expression of the hepatocellular carcinoma cell line (HUH7)

Pages

  1198-1202

Abstract

 Objective(s): Hepatocellular carcinoma (HCC) is one of the most significant health condition around the world. As the only curative therapies, liver transplantation and surgical resection are the clinical treatments of HCC. Due to the systemic toxicity and severe side effects of these treatments, it is vital to establish new therapeutic approaches. The present study aimed to compare cyclin D1 (CCN D1) gene expression in Hepatocellular carcinoma cell line (HUH7) when it is treated with Nanomicelle Curcumin and Sorafenib. The purpose was to identify toxicity risk and antioxidant activity of these drugs. Materials and Methods: The toxic dose (IC50) of Nanomicelle Curcumin and Sorafenib were detected after treatment of HUH7 cell lines with different dose of mentioned agents followed by MTT assay. CCN D1 gene expression was evaluated using real-time PCR. Following the Tukey’ s multiple comparison tests, statistical analysis is done through Student’ s t-test or ANOVA. Results: The expression of the CCN D1 gene was statistically significant (P<0. 001) at 289. 31, 128 and 152. 36 for Sorafenib, Nanomicelle Curcumin and SNC (Sorafenib-Nanomicelle Curcumin) respectively. The finding of this study revealed that, in comparison to Sorafenib alone, the treatment of HUH7 with a Nanomicelle Curcumin IC50 dose, in combination with Sorafenib, might down-regulate CCN D1 gene expression. Conclusion: The present research indicates that the treatment of the cell line with only Nanomicelle Curcumin results in the down-regulation of cyclin D1. To further decrease cyclin D1 expression, the co-delivery of Curcumin and Sorafenib appears to induce the apoptotic process. As a result, the effect of Sorafenib cytotoxicity and CCN D1 gene expression decreases twofold.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    HOSSEINI, SARE, CHAMANI, JAMSHIDKHAN, Sinichi, Mohadeseh, Bonakdar, Amir Mohammad, Azad, Zeinolabedin, ahangari, najmeh, & RAHIMI, HAMID REZA. (2019). The effect of nanomicelle curcumin, sorafenib, and combination of the two on the cyclin D1 gene expression of the hepatocellular carcinoma cell line (HUH7). IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 22(10), 1198-1202. SID. https://sid.ir/paper/730139/en

    Vancouver: Copy

    HOSSEINI SARE, CHAMANI JAMSHIDKHAN, Sinichi Mohadeseh, Bonakdar Amir Mohammad, Azad Zeinolabedin, ahangari najmeh, RAHIMI HAMID REZA. The effect of nanomicelle curcumin, sorafenib, and combination of the two on the cyclin D1 gene expression of the hepatocellular carcinoma cell line (HUH7). IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES[Internet]. 2019;22(10):1198-1202. Available from: https://sid.ir/paper/730139/en

    IEEE: Copy

    SARE HOSSEINI, JAMSHIDKHAN CHAMANI, Mohadeseh Sinichi, Amir Mohammad Bonakdar, Zeinolabedin Azad, najmeh ahangari, and HAMID REZA RAHIMI, “The effect of nanomicelle curcumin, sorafenib, and combination of the two on the cyclin D1 gene expression of the hepatocellular carcinoma cell line (HUH7),” IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, vol. 22, no. 10, pp. 1198–1202, 2019, [Online]. Available: https://sid.ir/paper/730139/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button